REGENOSINE, INC.
Harnessing the healing potential of adenosine for tissue regeneration
Princeton, United States · Founded 2021
- Headquarters
- Princeton, New Jersey
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Website
- regenosine.com
About
Regenosine is a preclinical-stage pharmaceutical company developing a proprietary liposomal adenosine formulation that targets the purinergic system to regenerate cartilage and halt osteoarthritis progression. The slow-release intraarticular injection delivers up to 15 days of joint exposure and has demonstrated significant pain relief and cartilage regeneration in validated models. The company's goal is to offer a disease-modifying therapy that improves clinical outcomes while reducing total healthcare delivery costs.
Summary
REGENOSINE, INC. is a Biotech company based in Princeton, United States, founded in 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/regenosine-inc"><img src="https://indexed.vc/api/badge/company/regenosine-inc" alt="REGENOSINE, INC. on Indexed.vc" width="260" height="76" /></a>